Bone complications in patients with Cushing's syndrome: Looking for clinical, biochemical, and genetic determinants

Osteoporosis International

Volumn 25, Issue 3, 2014, Pages 913-921

  Trementino, L ^a   Appolloni, G ^a   Ceccoli, L ^a   Marcelli, G ^a   Concettoni, C ^a   Boscaro, M ^a   Arnaldi, G ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Bone complications; Bone fractures; Cushing's syndrome; Glucocorticoid receptor polymorphisms

Indexed keywords

GLUCOCORTICOID RECEPTOR;

ADULT; AGED; BONE DENSITY; COMPLICATION; CUSHING SYNDROME; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SEX DIFFERENCE; SPINAL FRACTURES; YOUNG ADULT;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; BONE DENSITY; CUSHING SYNDROME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; POLYMORPHISM, GENETIC; RECEPTORS, GLUCOCORTICOID; RETROSPECTIVE STUDIES; SEX FACTORS; SPINAL FRACTURES; YOUNG ADULT;

EID: 84894550589     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-013-2520-5     Document Type: Article

References (28)

1. Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing's syndrome: a population-based study. J Clin Endocrinol Metab 86:117-123
2. Clayton RN, Raskauskiene D, Reulen RC, Jones PW (2011) Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab 96(3):632-642
3. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M (2003) Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 88(12):5593-5602
4. Arnaldi G, Mancini T, Tirabassi G, Trementino L, Boscaro M (2012) Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications. J Endocrinol Invest 35(4):434-448
5. Canalis E, Bilezikian JP, Angeli A, Giustina A (2004) Perspectives on glucocorticoid-induced osteoporosis. Bone 34:593-598
6. Chiodini I, Torlontano M, Carnevale V, Trischitta V, Scillitani A (2008) Skeletal involvement in adult patients with endogenous hypercortisolism. J Endocrinol Invest 31(3):267-276
7. Kaltsas G, Makras P (2010) Skeletal diseases in Cushing's syndrome: osteoporosis versus arthropathy. Neuroendocrinology 92(Suppl 1):60-64
8. Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224-3229
9. Valassi E, Santos A, Yaneva M et al (2011) The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 165:383-392
10. Tauchmanovà L, Pivonello R, Di Somma C et al (2006) Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status. J Clin Endocrinol Metab 91:1779-1784
11. Huizenga NA, Koper JW, de Lange P, Pols HA, Stolk RP, Grobbee DE, de Jong FH, Lamberts SW (1998) Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. J Clin Endocrinol Metab 83:47-54
12. Zhou J, Cidlowski JA (2005) The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 70:407-417
13. van Rossum EF, Lamberts SW (2004) Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res 59:333-357
14. Manenschijn L, van den Akker Erica LT, Lamberts Steven WJ, van Rossum Elisabeth FC (2009) Clinical features associated with glucocorticoid receptor polymorphisms: an overview. Ann N Y Acad Sci 1179:179-198
15. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93(5):152-640
16. Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML, Kalkwarf HJ, Langman CB, Plotkin H, Rauch F, Zemel BS, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Silverman S (2008) International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 43(6):1115-1121
17. Genant HK, Wu CY, Van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137-1148
18. Santos-Montes A, Gonzalo-Lumbreras R, Izquierdo-Hornillos R (1995) Simultaneous determination of cortisol and cortisone in urine by reversed-phase high-performance liquid chromatography. Clinic and doping control application. J Chromatogr 673:27-33
19. Karavitaki N, Ioannidis G, Giannakopoulos F, Mavrokefalos P, Thalassinos N (2004) Evaluation of bone mineral density of the peripheral skeleton in pre and postmenopausal women with newly diagnosed endogenous Cushing's syndrome. Clin Endocrinol (Oxford) 60:264-270
20. Pecori Giraldi F, Moro M, Cavagnini F (2003) Gender-related differences in the presentation and course of Cushing's disease. J Clin Endocrinol Metab 88:1554-1158
21. Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H, Grobbee DE, Brinkmann AO, De Jong FH, Lamberts SW (1998) A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 83:144-151
22. van Schoor NM, Dennison E, Lips P, Uitterlinden AG, Cooper C (2007) Serum fasting cortisol in relation to bone, and the role of genetic variations in the glucocorticoid receptor. Clin Endocrinol (Oxford) 67:871-878
23. Szappanos A, Patócs A, Tõke J, Boyle B, Sereg M, Majnik J, Borgulya G, Varga I, Likó I, Rácz K, Tóth M (2009) BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism. Clin Endocrinol (Oxford) 71(5):636-643
24. Morelli V, Donadio F, Eller-Vainicher C, Cirello V, Olgiati L, Savoca C, Cairoli E, Salcuni AS, Beck-Peccoz P, Chiodini I (2010) Role of glucocorticoid receptor polymorphism in adrenal incidentalomas. Eur J Clin Invest 40(9):803-811
25. Tzanela M, Mantzou E, Saltiki K, Tampourlou M, Kalogeris N, Hadjidakis D, Tsagarakis S, Alevizaki M (2012) Clinical and biochemical impact of BCL1 polymorphic genotype of the glucocorticoid receptor gene in patients with adrenal incidentalomas. J Endocrinol Invest 35(4):395-400
26. Trementino L, Appolloni G, Concettoni C, Cardinaletti M, Boscaro M, Arnaldi G (2012) Association of Glucocorticoid Receptor Polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome. Eur J Endocrinol 166(1):35-42
27. Hofbauer LC, Brueck CC, Singh SK, Dobnig H (2007) Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 22(9):1317-1328
28. Hamann C, Kirschner S, Günther KP, Hofbauer LC (2012) Bone, sweet bone - osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol 8(5):297-305